Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients

BackgroundA validated prediction model estimates the absolute benefit of intensive versus standard lipid‐lowering therapy (LLT) with statins on next major cardiovascular events for individual patients with coronary artery disease. We aimed to assess whether targeting intensive LLT therapy to coronar...

Full description

Bibliographic Details
Main Authors: Manon C. Stam‐Slob, Yolanda van der Graaf, Jacoba P. Greving, Jannick A.N. Dorresteijn, Frank L.J. Visseren
Format: Article
Language:English
Published: Wiley 2017-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
coronary artery disease
cost‐effectiveness
quality adjusted life years
statin therapy
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.004648

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.116.004648

Similar Items